Cargando…
Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360792/ https://www.ncbi.nlm.nih.gov/pubmed/25798446 http://dx.doi.org/10.1212/NXI.0000000000000084 |
_version_ | 1782361584537960448 |
---|---|
author | Weber, Martin S. |
author_facet | Weber, Martin S. |
author_sort | Weber, Martin S. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4360792 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-43607922015-03-20 Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS? Weber, Martin S. Neurol Neuroimmunol Neuroinflamm Editorial Lippincott Williams & Wilkins 2015-03-12 /pmc/articles/PMC4360792/ /pubmed/25798446 http://dx.doi.org/10.1212/NXI.0000000000000084 Text en © 2015 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially. |
spellingShingle | Editorial Weber, Martin S. Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS? |
title | Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS? |
title_full | Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS? |
title_fullStr | Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS? |
title_full_unstemmed | Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS? |
title_short | Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS? |
title_sort | is intrathecal anti-cd20 an option to target compartmentalized cns inflammation in progressive ms? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360792/ https://www.ncbi.nlm.nih.gov/pubmed/25798446 http://dx.doi.org/10.1212/NXI.0000000000000084 |
work_keys_str_mv | AT webermartins isintrathecalanticd20anoptiontotargetcompartmentalizedcnsinflammationinprogressivems |